Resultaten visas 1 - 10 / 358
resultat / per sida
Vilka publikationsuppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År

Drug screening approach combines epigenetic sensitization with immunochemotherapy in cancer

Referentgranskad
Öppen tillgång
DOI
10.1186/s13148-019-0781-3
Facciotto, Chiara; Casado, Julia; Turunen, Laura; Leivonen, Suvi-Katri; Tumiati, Manuela; Rantanen, ...
Clinical epigenetics2019

Reprogramming of Fibroblasts to Human iPSCs by CRISPR Activators

Referentgranskad
Öppen tillgång
DOI
10.1007/978-1-0716-1084-8_12
Weltner, Jere; Trokovic, Ras
Methods in Molecular Biology2021

HIF1α-PHD1-FOXA1 Axis Orchestrates Hypoxic Reprogramming and Androgen Signaling Suppression in Prostate Cancer

Referentgranskad
Öppen tillgång
DOI
10.3390/cells14131008
Liang, Limiao; Dong, Dandan; Sun, Jiaxue; Zhang, Qin; Yang, Xiayun; Wei, Gong-Hong; Zhang, Peng
Cells2025

Characteristics of epigenetic aging across gestational and perinatal tissues

Referentgranskad
Öppen tillgång
DOI
10.1186/s13148-021-01080-y
Dieckmann, Linda; Lahti-Pulkkinen, Marius; Kvist, Tuomas; Lahti, Jari; DeWitt, Peter E.; Cruceanu, C...
Clinical epigenetics2021

Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancer

Referentgranskad
Öppen tillgång
DOI
10.1002/1878-0261.12894
Mohammad Askandar Iqbal; Shumaila Siddiqui; Asad Ur Rehman; Farid Ahmad Siddiqui; Prithvi Singh; Bhu...
Molecular oncology2021

CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells

Referentgranskad
Öppen tillgång
DOI
10.1016/j.stemcr.2021.12.017
Sokka, Juho Joonas; Yoshihara, Masahito; Kvist, Jouni; Laiho, Laura; Warren, Andrew; Stadelmann, Chr...
Stem cell reports2022

TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming

Referentgranskad
DOI
10.1158/0008-5472.CAN-06-1986
Iljin, Kristiina; Wolf, Maija; Edgren, Henrik; Gupta, Santosh; Kilpinen, Sami; Skotheim, Rolf; Pelto...
Cancer Research2006

Novel Approaches for Pluripotent Reprogramming

Öppen tillgång
Weltner, Jere
Helsingin yliopisto2018

Chromatin reprogramming in breast cancer

Referentgranskad
Öppen tillgång
DOI
10.1530/ERC-18-0033
Swinstead, Erin E; Paakinaho, Ville; Hager, Gordon L
Endocrine-related cancer2018

Transcriptional reprogramming during floral fate acquisition

Referentgranskad
Öppen tillgång
DOI
10.1016/j.isci.2022.104683
Larrieu, Antoine; Brunoud, Geraldine; Guerault, Aurore; Laine, Stephanie; Hennet, Lauriane; Stiglian...
iScience2022

Drug screening approach combines epigenetic sensitization with immunochemotherapy in cancer

Referentgranskad
Öppen tillgång
DOI
10.1186/s13148-019-0781-3
2019

Reprogramming of Fibroblasts to Human iPSCs by CRISPR Activators

Referentgranskad
Öppen tillgång
DOI
10.1007/978-1-0716-1084-8_12
2021

HIF1α-PHD1-FOXA1 Axis Orchestrates Hypoxic Reprogramming and Androgen Signaling Suppression in Prostate Cancer

Referentgranskad
Öppen tillgång
DOI
10.3390/cells14131008
2025

Characteristics of epigenetic aging across gestational and perinatal tissues

Referentgranskad
Öppen tillgång
DOI
10.1186/s13148-021-01080-y
2021

Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancer

Referentgranskad
Öppen tillgång
DOI
10.1002/1878-0261.12894
2021

CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells

Referentgranskad
Öppen tillgång
DOI
10.1016/j.stemcr.2021.12.017
2022

TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming

Referentgranskad
DOI
10.1158/0008-5472.CAN-06-1986
2006

Novel Approaches for Pluripotent Reprogramming

Öppen tillgång
2018

Chromatin reprogramming in breast cancer

Referentgranskad
Öppen tillgång
DOI
10.1530/ERC-18-0033
2018

Transcriptional reprogramming during floral fate acquisition

Referentgranskad
Öppen tillgång
DOI
10.1016/j.isci.2022.104683
2022